Literature DB >> 15968270

DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion.

Giulia B Celli1, Titia de Lange.   

Abstract

Telomere attrition and other forms of telomere damage can activate the ATM kinase pathway. What generates the DNA damage signal at mammalian chromosome ends or at other double-strand breaks is not known. Telomere dysfunction is often accompanied by disappearance of the 3' telomeric overhang, raising the possibility that DNA degradation could generate the structure that signals. Here we address these issues by studying telomere structure after conditional deletion of mouse TRF2, the protective factor at telomeres. Upon removal of TRF2 from TRF2(F/-) p53-/- mouse embryo fibroblasts, a telomere damage response is observed at most chromosome ends. As expected, the telomeres lose the 3' overhang and are processed by the non-homologous end-joining pathway. Non-homologous end joining of telomeres was abrogated in DNA ligase IV-deficient (Lig4-/-) cells. Unexpectedly, the telomeres of TRF2-/- Lig4-/- p53-/- cells persisted in a free state without undergoing detectable DNA degradation. Notably, the telomeres retained their 3' overhangs, but they were recognized as sites of DNA damage, accumulating the DNA damage response factors 53BP1 and gamma-H2AX, and activating the ATM kinase. Thus, activation of the ATM kinase pathway at chromosome ends does not require overhang degradation or other overt DNA processing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15968270     DOI: 10.1038/ncb1275

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  300 in total

1.  Rap1-independent telomere attachment and bouquet formation in mammalian meiosis.

Authors:  Harry Scherthan; Agnel Sfeir; Titia de Lange
Journal:  Chromosoma       Date:  2010-10-07       Impact factor: 4.316

2.  Fission yeast Cactin restricts telomere transcription and elongation by controlling Rap1 levels.

Authors:  Luca E Lorenzi; Amadou Bah; Harry Wischnewski; Vadim Shchepachev; Charlotte Soneson; Marco Santagostino; Claus M Azzalin
Journal:  EMBO J       Date:  2014-11-14       Impact factor: 11.598

Review 3.  Mechanisms and regulation of DNA end resection.

Authors:  Maria Pia Longhese; Diego Bonetti; Nicola Manfrini; Michela Clerici
Journal:  EMBO J       Date:  2010-07-20       Impact factor: 11.598

4.  Persistent telomere damage induces bypass of mitosis and tetraploidy.

Authors:  Teresa Davoli; Eros Lazzerini Denchi; Titia de Lange
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

5.  Mammalian Rap1 widens its impact.

Authors:  Laure Crabbe; Jan Karlseder
Journal:  Nat Cell Biol       Date:  2010-08       Impact factor: 28.824

6.  A Shld1-controlled POT1a provides support for repression of ATR signaling at telomeres through RPA exclusion.

Authors:  Yi Gong; Titia de Lange
Journal:  Mol Cell       Date:  2010-11-12       Impact factor: 17.970

Review 7.  Assessing cell and organ senescence biomarkers.

Authors:  Bruno Bernardes de Jesus; Maria A Blasco
Journal:  Circ Res       Date:  2012-06-22       Impact factor: 17.367

8.  DUB-resistant ubiquitin to survey ubiquitination switches in mammalian cells.

Authors:  Miklós Békés; Keiji Okamoto; Sarah B Crist; Mathew J Jones; Jessica R Chapman; Bradley B Brasher; Francesco D Melandri; Beatrix M Ueberheide; Eros Lazzerini Denchi; Tony T Huang
Journal:  Cell Rep       Date:  2013-11-07       Impact factor: 9.423

9.  Isolation of chromatin from dysfunctional telomeres reveals an important role for Ring1b in NHEJ-mediated chromosome fusions.

Authors:  Cristina Bartocci; Jolene K Diedrich; Iliana Ouzounov; Julia Li; Andrea Piunti; Diego Pasini; John R Yates; Eros Lazzerini Denchi
Journal:  Cell Rep       Date:  2014-05-09       Impact factor: 9.423

10.  Disruption of direct 3D telomere-TRF2 interaction through two molecularly disparate mechanisms is a hallmark of primary Hodgkin and Reed-Sternberg cells.

Authors:  Hans Knecht; Nathalie A Johnson; Tina Haliotis; Daniel Lichtensztejn; Sabine Mai
Journal:  Lab Invest       Date:  2017-04-24       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.